Dystonia: Clinical features, genetics, and treatment

Current Opinion in Neurology

Volumn 15, Issue 4, 2002, Pages 491-497

  Klein, Christine ^a   Ozelius, Laurie J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Classification; Dystonia; Genetics; Treatment

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

BRAIN DEPTH STIMULATION; CLINICAL FEATURE; DENERVATION; DYSTONIA; GENE; GENE LOCUS; GENE MAPPING; GENE MUTATION; HUMAN; MEDICAL GENETICS; MYOCLONUS; NERVE STIMULATION; PALLIDOTOMY; PHENOTYPE; REVIEW; SGCE GENE;

CARRIER PROTEINS; DYSTONIA; HUMANS; MOLECULAR CHAPERONES;

EID: 0036311809     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200208000-00014     Document Type: Review

References (92)

1. Classification of dystonia
2. Genetics of primary dystonia
3. Clinical and molecular genetics of primary dystonias
4. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36,13-36.32 in an Italian family with cranial-cervical or upper limb onset
5. Hereditary torsion dystonia in gypsies
6. Hereditary whispering dysphonia
7. Phenotypic expression of the DYT1 mutation: A family with writer's cramp of juvenile onset
8. The DYT1 phenotype and guidelines for diagnostic testing
9. The DYT1 mutation and ponfamilial primary torsion dystonia
10. Idiopathic torsion dystonia linked to chromosome 8 in two Mennonite families
11. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
12. Dystonia in Ashkenazi Jews: Clinical characterization of a founder mutation
13. Frequency of the DYT1 mutation in primary torsion dystonia without family history
14. No evidence of allelic heterogeneity in the DYT1 gene of European patients with early onset torsion dystonia
15. GAG deletion in the DYT1 gene in early limb-onset idiopathic torsion dystonia in Germany
16. DYT1 mutation in primary torsion dystonia in a Serbian population
17. The role of primary torsion dystonia in Europe
18. AAA+: A class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes
19. TorsinA: Movement at many levels
20. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells
21. Torsin A and its torsion dystonia-associated mutant forms are lumenal glycoproteins that exhibit distinct subcellular localizations
22. Primary dystonias: A review of the pathology and suggestions for new directions of study
23. TorsinA immunoreactivity in brains of patients with DYT1 and non-DYT1 dystonia
24. Expression of the early-onset torsion dystonia gene (DYT1) in human brain
25. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult brain
26. Immunohistochemical localization and distribution of torsinA in normal human and rat brain
27. Cellular distribution of torsinA and torsinB in normal human brain
28. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease
29. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies
30. To test or not? The value of diagnostic tests in cervical dystonia
31. Task-specific dystonia in a horn player
32. Playing harp, another unusual task-specific dystonia
33. A genetic study of idiopathic focal dystonias
34. Cervical dystonia in monozygotic twins: Case report and review of the literature
35. Prospective clinical study of writer's cramp
36. Idiopathic torsion dystonia: Assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution
37. Primary torsion dystonia: The search for genes is not over
38. Search for a founder mutation in idiopathic focal dystonia from Northern Germany
39. Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene
40. A polymorphism in the dopamine receptor DRD5 is associated with blepharospasm
41. Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP)
42. Familial (idiopathic) paroxysmal dyskinesias: An update
43. Hereditary progressive dystonia with marked diurnal fluctuation
44. Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: Diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency
45. Atypical presentation of dopa-responsive dystonia: Generalized hypotonia and proximal weakness
46. Neurologic and psychiatric manifestations in a family with a mutation in exon 2 of the guanosine triphosphate-cyclohydrolase gene
47. Dopa-responsive dystonia. Some pieces of the puzzle are still missing
48. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene
49. Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts
50. Hereditary essential myoclonus
51. Inherited myoclonus-dystonia syndrome
52. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome
53. Association of a missense change in the D2 dopamine receptor with myoclonus dystonia
54. Evaluation of the role of the D2 dopamine receptor in myoclonus dystonia
55. D2 dopamine receptor gene in myoclonic dystonia and essential myoclonus
56. A major locus for several phenotypes of myoclonus-dystonia on chromosome 7q
57. Inherited myoclonusdystonia: Evidence supporting genetic heterogeneity
58. Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31
59. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families
60. Inherited myoclonus-dystonia syndrome: Narrowing the 7q21-q31 locus in German families
61. Sarooglycan isoforms in skeletal muscle
62. Novel mutation in the Tor1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism
63. The spectrum of myoclonus dystonia: Possible association with OCD and alcohol dependence
64. Early morning off-medication dyskinesias, dystonia, and choreic subtypes
65. Dystonia in corticobasal degeneration
66. Neurologic findings in Machado-Joseph disease
67. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of hereditary ataxia
68. Dystonia in Wilson's disease
69. Clinical characteristics and topography of lesions in movement disorders due to thalamic lesions
70. Treatment of tremor and dystonia
71. Dystonia
72. Response to levodopa treatment in dopa-responsive dystonia
73. Torsion dystonia: A double blind, prospective trial of high dosage trihexyphenidyl
74. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs
75. Baclofen in the treatment of idiopathic dystonia in children
76. Tetrabenazine treatment in dystonia, chorea, tics, and other dyskinesias
77. Pathophysiology and treatment of cranial dystonia
78. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia
79. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia
80. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia
81. Outcome of selective ramisectomy for botulinum toxin resistant torticollis
82. Symptomatic and functional outcome of surgical treatment of cervical dystonia
83. Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia
84. Prospective study of swallowing function in patients with cervical dystonia undergoing selective peripheral denervation
85. Review of the functional surgical treatment of dystonia
86. Globus pallidus internus pallidotomy for generalized dystonia
87. Functional recovery after bilateral pallidotomy for the treatment of early-onset primary generalized dystonia
88. Globus pallidus deep brain stimulation for generalized dystonia: Clinical and PET investigation
89. Treatment of DYT1: Generalized dystonia by stimulation of the internal globus pallidus
90. Bilateral pallidal stimulation for idiopathic segmental axial dystonia advanced from Meige syndrome refractory to bilateral thalamotomy
91. Neurostimulation of the ventral intermediate thalamic nucleus in inherited myoclonus-dystonia syndrome
92. Pallidal and thalamio neurostimulation in severe tardive dystonia